Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients

Withdrawn before enrolling · Phase 4

Conditions studied: Hyperglycemia in Pregnant Diabetic Patients

In brief

Our objective is to assess whether pre-treatment with a fixed dose of insulin, based on weight, given to pregnant patients with gestational or preexisting diabetes receiving betamethasone can provide adequate glycemic control. Our hypothesis is that pre-treatment with a weight-based calculated insulin dose will help maintain euglycemia for pregnant patients with gestational and preexisting diabetes after steroid administration, and possibly impact length of hospital admission.

Key facts

Study ID

NCT01875107

Run by

University of Minnesota

People needed

0

Starts

2013-08-01

Expected to finish

2014-08-01

Last updated by the study team

2014-09-12

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant women with gestational or pre-existing diabetes admitted to the University of Minnesota
• Must be 18 years or older
• Must speak English, Spanish, or Somali
• Patients must receive steroids for fetal lung maturity as part of their hospital course

You may not qualify if…

• Pregnant women with Type 1 Diabetes, or Type 2 diabetes with evidence of end-organ disease
• Pregnant women who need to be emergently delivered due to maternal or fetal complications of pregnancy

Where it is running

• University of Minnesota Medical Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.